EUVIMEDEUVIMED entdecken
Crossref

Screening Asian Medicinal Plants for SARS‐CoV‐2 Inhibitors: A Computational Approach

Hira Khalid, Iqra Ahmad, Asifa Sarfraz, Anwar Iqbal, Umar Nishan, Hanna Dib, Riaz Ullah, Sheheryar Sheheryar, Mohibullah Shah iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Hira Khalid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Bahauddin Zakariya University, Multan, 66000, Pakistan. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Plants, Medicinal, Coronavirus 3C Proteases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work aimed to evaluate the antiviral potential of compounds from Asian medicinal plants against SARS‐CoV‐2's main protease and spike glycoprotein, identifying dual inhibitors from these plants that target both proteins through advanced virtual screening, molecular dynamics simulations, and pharmacophore analysis. An in‐house library of 335 antiviral natural products was prepared from the selected medicinal plants. Following the virtual screening of this library against the main protease and spike glycoprotein, top compounds were subjected to downstream analysis for evaluating druggability potential and toxicity analysis. Molecular dynamic simulations were performed to confirm the stability of interactions between the ligands and target proteins. Our analysis demonstrated 67 compounds as dual inhibitors. The six top dual inhibitors, namely trans‐ delta‐viniferin, trans‐ E‐viniferin, 3,4‐DHPEA‐EDA, oleuropein aglycone, lactucopicrin, and 11β,13‐dihydrolactucopicrin, exhibited superior docking scores and met drug‐likeness criteria, including Lipinski's rule, bioavailability, and favorable ADME and toxicity profiles. Trans‐ delta‐viniferin and trans‐ E‐viniferin, featuring a stilbene scaffold, emerged as the most promising candidates due to their stable interactions, minimal fluctuations, and consistent hydrogen bonding across SARS‐CoV‐2's Mpro and S‐protein in MD simulations, while 3,4‐DHPEA‐EDA displayed comparatively less stability. All compounds demonstrated key pharmacophoric features and lacked mutagenicity or PAINS alerts, although lactucopicrin and 11β,13‐dihydrolactucopicrin showed risks for hepatotoxicity. Overall, the critical bonding and drug‐like features, biological activity spectra, and favorable medicinal characteristics predict their biological behavior in laboratory testing. Although additional experimental validations are necessary, our findings indicate that the three lead compounds—namely, trans‐ delta‐viniferin, trans ‐E‐viniferin, and 3,4‐DHPEA‐EDA, isolated from traditional medicinal plants—are promising novel dual inhibitors of two critical SARS‐CoV‐2 proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2Plants, MedicinalCoronavirus 3C ProteasesCOVID-19 Drug TreatmentMolecular Docking SimulationHumansMolecular Dynamics SimulationSpike Glycoprotein, CoronavirusDrug Evaluation, Preclinical

Stichwörter der Autor:innen

COVID‐19drug designingin silicomedicinalnatural productstoxicity

Substanzen

Antiviral AgentsCoronavirus 3C ProteasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Biochemistry, Bahauddin Zakariya University, Multan, 66000, Pakistan.
  • Department of Chemical Sciences, University of Lakki Marwat, Khyber Pakhtunkhwa, Pakistan.
  • Hainan International Joint Research Center of Marine Advanced Photoelectric Functional Materials, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, China.
  • Department of Chemistry, Kohat University of Science & Technology, Kohat, Pakistan.
  • College of Engineering and Technology, American University of the Middle East, Kuwait.
  • Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Mohibullah Shah

Zitieren

APA

Khalid, H., Ahmad, I., Sarfraz, A., Iqbal, A., Nishan, U., Dib, H., Ullah, R., Sheheryar, S., & Shah, M. (2025). Screening Asian Medicinal Plants for SARS‐CoV‐2 Inhibitors: A Computational Approach. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402548

Vancouver

Khalid H, Ahmad I, Sarfraz A, Iqbal A, Nishan U, Dib H, et al. Screening Asian Medicinal Plants for SARS‐CoV‐2 Inhibitors: A Computational Approach. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402548

BibTeX
@article{Khalid2025,
  author = {Khalid, Hira and Ahmad, Iqra and Sarfraz, Asifa and Iqbal, Anwar and Nishan, Umar and Dib, Hanna and Ullah, Riaz and Sheheryar, Sheheryar and Shah, Mohibullah},
  title = {Screening Asian Medicinal Plants for SARS‐CoV‐2 Inhibitors: A Computational Approach},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402548}
}
Kostenlos starten →